Hutchinson Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $325K | Buy |
5,647
+2,029
| +56% | +$117K | 0.06% | 87 |
|
|
2026
Q1 | $219K | Buy |
+3,618
| New | +$211K | 0.04% | 92 |
|
|
2025
Q2 | – | Sell |
-4,230
| Closed | -$258K | – | 93 |
|
|
2025
Q1 | $258K | Sell |
4,230
-89
| -2% | -$5.19K | 0.05% | 79 |
|
|
2024
Q4 | $244K | Buy |
4,319
+21
| +0.5% | +$1.17K | 0.05% | 83 |
|
|
2024
Q3 | $222K | Buy |
+4,298
| New | +$202K | 0.04% | 85 |
|
|
2024
Q2 | – | Sell |
-4,255
| Closed | -$231K | – | 88 |
|
|
2024
Q1 | $231K | Sell |
4,255
-26
| -0.6% | -$1.32K | 0.05% | 79 |
|
|
2023
Q4 | $220K | Buy |
4,281
+56
| +1% | +$2.94K | 0.05% | 79 |
|
|
2023
Q3 | $245K | Sell |
4,225
-56
| -1% | -$3.43K | 0.06% | 73 |
|
|
2023
Q2 | $274K | Buy |
4,281
+27
| +0.6% | +$1.81K | 0.06% | 70 |
|
|
2023
Q1 | $295K | Sell |
4,254
-96
| -2% | -$6.77K | 0.08% | 61 |
|
|
2022
Q4 | $313K | Buy |
4,350
+13
| +0.3% | +$980 | 0.08% | 60 |
|
|
2022
Q3 | $308K | Sell |
4,337
-130
| -3% | -$9.43K | 0.08% | 61 |
|
|
2022
Q2 | $344K | Buy |
4,467
+80
| +2% | +$6.09K | 0.09% | 58 |
|
|
2022
Q1 | $320K | Buy |
4,387
+38
| +0.9% | +$2.55K | 0.07% | 63 |
|
|
2021
Q4 | $271K | Buy |
4,349
+30
| +0.7% | +$1.76K | 0.06% | 66 |
|
|
2021
Q3 | $256K | Hold |
4,319
| – | – | 0.06% | 62 |
|
|
2021
Q2 | $289K | Buy |
4,319
+80
| +2% | +$5.22K | 0.07% | 59 |
|
|
2021
Q1 | $268K | Hold |
4,239
| – | – | 0.07% | 60 |
|
|
2020
Q4 | $263K | Hold |
4,239
| – | – | 0.07% | 62 |
|
|
2020
Q3 | $256K | Sell |
4,239
-33
| -0.8% | -$1.99K | 0.08% | 62 |
|
|
2020
Q2 | $251K | Buy |
4,272
+34
| +0.8% | +$2.03K | 0.08% | 57 |
|
|
2020
Q1 | $236K | Buy |
4,238
+266
| +7% | +$16.3K | 0.08% | 58 |
|
|
2019
Q4 | $255K | Hold |
3,972
| – | – | 0.07% | 62 |
|
|
2019
Q3 | $201K | Buy |
+3,972
| New | +$187K | 0.05% | 67 |
|
|
2018
Q4 | – | Sell |
-3,780
| Closed | -$235K | – | 57 |
|
|
2018
Q3 | $235K | Hold |
3,780
| – | – | 0.07% | 54 |
|
|
2018
Q2 | $209K | Hold |
3,780
| – | – | 0.07% | 51 |
|
|
2018
Q1 | $239K | Hold |
3,780
| – | – | 0.07% | 47 |
|
|
2017
Q4 | $232K | Hold |
3,780
| – | – | 0.06% | 48 |
|
|
2017
Q3 | $241K | Sell |
3,780
-150
| -4% | -$8.76K | 0.07% | 46 |
|
|
2017
Q2 | $219K | Hold |
3,930
| – | – | 0.06% | 45 |
|
|
2017
Q1 | $214K | Sell |
3,930
-155
| -4% | -$8.5K | 0.06% | 46 |
|
|
2016
Q4 | $239K | Sell |
4,085
-150
| -4% | -$8.2K | 0.07% | 47 |
|
|
2016
Q3 | $228K | Sell |
4,235
-3,272
| -44% | -$210K | 0.07% | 44 |
|
|
2016
Q2 | $552K | Sell |
7,507
-610
| -8% | -$43.1K | 0.17% | 37 |
|
|
2016
Q1 | $519K | Buy |
8,117
+300
| +4% | +$18.9K | 0.16% | 36 |
|
|
2015
Q4 | $538K | Hold |
7,817
| – | – | 0.17% | 34 |
|
|
2015
Q3 | $463K | Hold |
7,817
| – | – | 0.15% | 40 |
|
|
2015
Q2 | $520K | Sell |
7,817
-200
| -2% | -$13.2K | 0.16% | 39 |
|
|
2015
Q1 | $517K | Sell |
8,017
-110
| -1% | -$6.89K | 0.16% | 43 |
|
|
2014
Q4 | $480K | Sell |
8,127
-50
| -0.6% | -$2.82K | 0.14% | 49 |
|
|
2014
Q3 | $419K | Sell |
8,177
-50
| -0.6% | -$2.5K | 0.12% | 48 |
|
|
2014
Q2 | $399K | Sell |
8,227
-1,025
| -11% | -$50.5K | 0.11% | 47 |
|
|
2014
Q1 | $481K | Sell |
9,252
-25
| -0.3% | -$1.33K | 0.14% | 42 |
|
|
2013
Q4 | $493K | Sell |
9,277
-1,950
| -17% | -$99.3K | 0.14% | 42 |
|
|
2013
Q3 | $520K | Buy |
11,227
+900
| +9% | +$39.5K | 0.17% | 40 |
|
|
2013
Q2 | $462K | Buy |
+10,327
| New | +$448K | 0.15% | 40 |
|
Other funds holding BMY
Hutchinson Capital Management's BMY Position: Q2 2026 in Review
Hutchinson Capital Management increased its Bristol-Myers Squibb (BMY) stake by 56% in Q2 2026, buying an estimated $117K and bringing the position to 5,647 shares worth $325K. The position accounts for 0.06% of the portfolio, ranked #87.
Hutchinson Capital Management first reported a position in BMY in Q2 2013 and has held it in 46 quarters since. The position peaked at $552K in Q2 2016. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Hutchinson Capital Management held 5,647 shares of Bristol-Myers Squibb worth $325K as of Q2 2026.
- Hutchinson Capital Management bought 2,029 Bristol-Myers Squibb shares in Q2 2026, an estimated $117K.
- Bristol-Myers Squibb made up 0.06% of Hutchinson Capital Management's portfolio in Q2 2026, its #87 holding.
- Hutchinson Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 46 quarters since.
- Hutchinson Capital Management's Bristol-Myers Squibb position peaked at $552K in Q2 2016.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Hutchinson Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.